glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Drugs: 2025 Pulse Survey

Table 3 Summary of the most common reported adverse events displayed by molecules and doses

Li JM et al

M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F

Navigating the Path for Weight Management While the launch of the generic liraglutide primarily targets diabetes treatment, it opens a potential pathway for those seeking it for weight management

Social media users have latched onto marketing techniques that equate the completely unrelated ingredients of natural Mounjaro drink with the medications weight loss results, said Stephani Johnson, DCN, RDN, an adjunct professor in the Department of Clinical and Preventive Nutrition Sciences at Rutgers University

Semaglutide GLP-1 is typically administered once a week, either via subcutaneous injection or a pre-filled pen